Clearpoint Neuro (CLPT) Stock Price
Clearpoint Neuro Price
Revenue has compounded at 18.9% per year over the past 17 years to 36.97 M USD. Clearpoint Neuro's net margin stands at -69.1%, up from -88.4% several years earlier. Analysts set a median price target of 23.50 USD, implying 148.9% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.
Clearpoint Neuro stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Clearpoint Neuro business model & stock analysis
Frequently asked questions about Clearpoint Neuro
Clearpoint Neuro Inc's business model focuses on developing and commercializing innovative medical devices for a variety of neurosurgical procedures. The company primarily specializes in providing advanced technology solutions for neurologists and neurosurgeons, empowering them to precisely deliver therapeutic interventions to the brain. Clearpoint Neuro Inc's flagship product, the ClearPoint Neuro Navigation System, enables real-time MRI-guided neurosurgery, enhancing accuracy and patient outcomes. By combining imaging technology with surgical instruments, the company aims to revolutionize neurosurgical procedures. Clearpoint Neuro Inc's business model revolves around providing cutting-edge solutions that improve the precision, safety, and efficacy of neurosurgical interventions, ultimately benefiting patients and healthcare professionals alike.
Clearpoint Neuro Inc is primarily active in the medical device industry.
The main competitors of Clearpoint Neuro Inc in the market include companies such as Medtronic, Inc., Stryker Corporation, and Brainlab AG.
Clearpoint Neuro Inc is a medical technology company specializing in the development and commercialization of devices for neurological procedures. Founded in 1999, Clearpoint Neuro has established itself as a leader in the field of image-guided neurosurgery. The company's innovative platform combines real-time MRI technology with surgical planning software, enabling precise targeting and accurate delivery of therapies to the brain. Clearpoint Neuro's devices have been utilized in various clinical applications, including the treatment of movement disorders, brain tumors, and epilepsy. With its commitment to advancing neurosurgical interventions, Clearpoint Neuro continues to push the boundaries of neuroscience to improve patient outcomes.
Clearpoint Neuro Inc has achieved several significant milestones. The company established itself as a leader in the field of neurosurgery by developing and commercializing a unique and innovative MRI-guided neurosurgical system called Clearpoint. This system allows precise and real-time guidance for brain surgeries, enhancing patient outcomes and reducing risks. In addition, Clearpoint Neuro Inc has successfully obtained regulatory clearances for its products in multiple countries, expanding its global reach. The company has also formed strategic partnerships with renowned medical institutions and received recognition for its advancements in neurosurgery. Clearpoint Neuro Inc continues to make advancements in the field, solidifying its position as a trusted provider of innovative neurosurgical solutions.
Clearpoint Neuro Inc is primarily present in the United States.
Clearpoint Neuro Inc represents values of innovation, patient-focused care, and collaboration in the field of neurosurgery and neuromodulation. The company strives to improve patient outcomes by developing advanced technologies and solutions tailored to meet the unique needs of neurosurgeons. Clearpoint Neuro is dedicated to providing precision-guided therapies and enabling targeted delivery of therapies to the brain. Their corporate philosophy emphasizes the importance of cutting-edge research, strategic partnerships, and continuous improvement to drive advancements in neurological treatments. With a commitment to excellence, Clearpoint Neuro aims to make a significant impact in the lives of patients suffering from neurological disorders.
Analysts currently set an average price target of 23.50 USD for the Clearpoint Neuro stock (median: 23.50 USD), implying +148.9 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Clearpoint Neuro stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Clearpoint Neuro to generate revenue of 49.00 M USD and earnings per share of -1.37 USD.
Converted at the current exchange rate, the Clearpoint Neuro share trades at 8.42 EUR (9.44 USD).
The Clearpoint Neuro share (CLPT) is listed on 1 stock exchanges, including: NASDAQ (CLPT).
Clearpoint Neuro Inc. is an innovative company in the field of medical devices and imaging technologies. The company is headquartered in Irvine, California and operates worldwide. Clearpoint Neuro offers a wide range of solutions for the assessment of brain and central nervous system diseases. Clearpoint Neuro's business model is based on several divisions. On one hand, the company specializes in the development of imaging technologies and surgical instruments for the placement of electrodes and catheters in the brain. This includes the Clearpoint Neuro Navigation System and the SmartFrame®. The Clearpoint Neuro Navigation System allows neurosurgeons to combine electrophysiological and imaging data in real-time during surgical procedures. With the support of this system, neurosurgeons can determine the position of electrodes and catheters more precisely to perform targeted therapies for patients with Parkinson's, epilepsy, and other neurological diseases. The SmartFrame® is an instrument for the placement of catheters and probes in the brain and spine. It provides an extremely precise and reliable method for positioning drug pumps and other instruments for the treatment of pain as well as neurological or psychiatric disorders. In addition, Clearpoint Neuro also offers services such as training medical professionals in the effective use of navigation technology and surgical instruments. A third division of the company is the Clearpoint Neuro Customer Service team. This team provides comprehensive support to customers for any questions related to products and services. It is available for all inquiries and offers training, technical support, and other services. Another important area is the sale of consumables such as catheters and electrodes for electrophysiology. The company has a wide range of high-performance catheters specifically designed for use with the Clearpoint Neuro Navigation System. Clearpoint Neuro also has strategic partnerships with leading medical institutions and research facilities worldwide. These partnerships contribute to the advancement and improvement of Clearpoint Neuro products and provide a platform for future innovations and technologies. In summary, Clearpoint Neuro offers a broad portfolio of products and services for the assessment and treatment of neurological and central nervous system diseases. The company is committed to meeting the needs and requirements of its customers by providing innovative technologies and collaborating closely with its growing customer base.
The expected revenue of Clearpoint Neuro is 49.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Clearpoint Neuro is -38.82 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Clearpoint Neuro is currently -6.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Clearpoint Neuro stock.
The price-to-sales ratio (P/S) of Clearpoint Neuro is currently 5.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Clearpoint Neuro stock.
The Eulerpool Quality Score for Clearpoint Neuro is 4/10.
The ISIN of Clearpoint Neuro is US18507C1036. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Clearpoint Neuro is A2PZ3E. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Clearpoint Neuro is CLPT. The ticker symbol is used to trade Clearpoint Neuro shares on the stock exchange.
Clearpoint Neuro stock
Clearpoint Neuro Peer Group
Clearpoint Neuro Ticker
Clearpoint Neuro FIGI
All fundamentals and in-depth analysis of Clearpoint Neuro
Our stock analysis for Clearpoint Neuro stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearpoint Neuro. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.